Monitor for actual Form 4 filings to confirm whether the sale was executed. Director-level sales of this size are not unusual for diversification, but the timing relative to any upcoming catalysts (e.g., pipeline updates, earnings) should be watched.
Price Chart
Executive Summary
Director George M. Milne Jr. filed a Form 144 notice of intent to sell 100,000 shares of Amylyx Pharmaceuticals (AMLX), with an estimated aggregate market value of approximately $2,779,000 based on the filing date. The shares were acquired in a private acquisition from the issuer in 2016 and through previously exercised options in 2019. This is an advance notice of a proposed sale by a director, not a completed transaction.
Key Facts
- Director George M. Milne Jr. filed Form 144 to sell 100,000 shares of AMLX common stock.
- Estimated aggregate market value of the proposed sale is approximately $2,779,000.
- Shares were acquired via private acquisition from issuer (2016) and previously exercised options (2019).
- The sale is proposed for the open market through Morgan Stanley Smith Barney LLC.
- Form 144 is an advance notice of intent to sell; the sale may or may not occur.
Financial Impact
Proposed sale of 100,000 shares valued at ~$2.78 million, representing a small fraction of the company's market cap.
Risk Factors
- Insider sale may signal reduced conviction if executed ahead of material negative news.
- Form 144 is only an intent to sell — the sale may not be completed.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010033 |
| Document: 0001950047-26-010033-index.html | 0001950047-26-010033 |
| Document: 0001950047-26-010033.txt | 0001950047-26-010033 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | 144 | $28.04 | awaiting T+20 | — | $27.20 (−3.00%) |
Sep 14, 2026 6w ago | Insider Cluster | $33.15 $26.85 | ▼ −19.00% | ▼ −21.73% | $27.20 (−17.95%) |
Sep 11, 2026 6w ago | 144 | $33.64 $27.48 | ▼ −18.31% | ▼ −20.57% | $27.20 (−19.14%) |
Aug 18, 2026 9w ago | 8-K | $35.11 $33.05 | ▼ −5.87% | ▼ −4.88% | $27.20 (−22.53%) |
Aug 15, 2026 10w ago | Institutional Cluster | $21.43 $33.15 | ▲ +54.69% | ▲ +56.67% | $27.20 (+26.92%) |
Aug 6, 2026 11w ago | 8-K | $24.19 $33.96 | ▲ +40.39% | ▲ +39.79% | $27.20 (+12.44%) |
Jun 11, 2026 19w ago | Institutional Cluster | $13.91 $18.38 | ▲ +32.14% | ▲ +30.24% | $27.20 (+95.54%) |
Apr 23, 2026 26w ago | DEFA14A | $17.32 $13.61 | ▼ −21.42% | ▼ −26.05% | $27.20 (+57.04%) |
Mar 2, 2026 34w ago | Insider Cluster | $15.30 $12.76 | ▼ −16.60% | ▼ −8.66% | $27.20 (+77.78%) |
Feb 23, 2026 35w ago | Insider Cluster | $13.90 $13.53 | ▲ +2.66% | ▼ −1.28% | $27.20 (−95.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers